Monoclonal antibody (mAb) therapies continue to provide both powerful weapons against disease and compelling business opportunities for forward-thinking companies.
Read MoreWhich is more sustainable: stainless steel or single-use systems?
What are the environmental impacts of single-use technology and stainless steel systems? And which should you use in your next facility?
Read More4 cell therapy manufacturing approaches: your guide to optimizing every square foot
Could your cell therapy manufacturing facility be working harder for you? If you have (or anticipate having) small-scale cell therapies in your pipeline, this question is vital.
Read MoreExpanding global operations with standard facility design
Increasingly, manufacturers want standard facility designs of their GMP manufacturing facilities so they can be replicated elsewhere in the world, but this approach comes with unique considerations.
Read MoreIn-house production vs. CDMO: meeting the challenges of commercializing cell and gene therapies
Commercializing cell and gene therapies efficiently requires timely decisions about whether to engage a CDMO or develop internal manufacturing capacity. Sometimes the best solution is to do both.
Read MoreThe dynamic future of life-saving medicine
Changing the way therapies work, and the changing work of making therapies.
Read MoreFill-finish in ATMP: 5 critical questions to ask on the way to process scale-up
To bring the exciting science of cell and gene therapy manufacturing to life, creating smaller-scale filling solutions is imperative to the success of the ATMP industry. But before you begin scaling your operation, there are important questions to consider about fill-finish in ATMP.
Read MoreZero carbon considerations for biotech facilities and operations
Your life sciences company can strive for zero carbon on your next project. Here’s how.
Read MorePartnering for speed: when global expertise meets local knowledge
Embracing the notion of a hybrid partner will support Europe-based life science innovators in delivering drug therapies faster and more cost-effectively.
Read MoreAn introduction to ATMP manufacturing
Advanced Therapy Medicinal Products (ATMPs) are changing the face of medicine, but with all the opportunity and rapid change comes a host of challenges. Here’s a look at the state of the ATMP industry and important considerations for manufacturers chasing success.
Read More